Please login to the form below

Not currently logged in
Email:
Password:

product launches

This page shows the latest product launches news and features for those working in and with pharma, biotech and healthcare.

Is GSK planning to exit the respiratory business?

Is GSK planning to exit the respiratory business?

product that has brought in more than $100bn in sales since its launch in 2001. ... to an explosion of new studies and product launches in immuno-oncology.

Latest news

  • GSK gets maintenance indication for Trelegy GSK gets maintenance indication for Trelegy

    GlaxoSmithKline is celebrating an expanded US approval for its triple respiratory drug Trelegy, which it has long held up as one of its most important new product launches. ... The new product is still very much in its roll-out phase after getting FDA

  • Gilead’s triple HIV drug approval prompts GSK lawsuit Gilead’s triple HIV drug approval prompts GSK lawsuit

    The US FDA approved Gilead Sciences’triple-drug Biktarvy product for HIV this week, but the company’s celebrations were swiftly undermined by a legal challenge from GlaxoSmithKline. ... which was first approved in the US in 2013 and is a key

  • AZ expects return to growth this year after 2017 decline AZ expects return to growth this year after 2017 decline

    in sales in China, although the cost of new product launches pegged back fourth-quarter profit.

  • 2018 by Darwin 2018 by Darwin

    Only a minority of such new product launches fulfil the promises made to their risk-exposed investors. ... We already see patients and their carers strongly influencing product choice in many pharma and medtech markets.

  • Merck forges closer ties with Cancer Research UK Merck forges closer ties with Cancer Research UK

    Its pipeline is currently spearheaded by PD-L1 inhibitor Bavencio (avelumab), partnered with Pfizer, and comes after a lean few years at the German company with few product launches and some

More from news
Approximately 0 fully matching, plus 142 partially matching documents found.

Latest Intelligence

  • Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

    PME talks to its European leader Theresa Heggie. Even as it launches its first ever product Onpattro, Alnylam is already a biotech industry case study. ... and sustainable clinical pipeline and a robust product engine by the end of 2020; a company

  • Positive disruption in business intelligence Positive disruption in business intelligence

    During the years before a product launches, HCP ‘digital opinion leaders’ - online HCP influencers in a particular therapy area - may be identified who are advocating for a new product in development. ... Tactical opportunities. Listening to

  • Beyond the annual plan Beyond the annual plan

    In the last five years, the pharmaceutical industry has shifted from blockbusters in primary care to an increased number of high value specialty launches. ... This means more product launches in more indications, marketed to larger audiences than ever

  • ‘Dear Pharma, stop talking, start delivering’ ‘Dear Pharma, stop talking, start delivering’

    Hence, the resulting services and apps cater to one specific product or perhaps one disease. ... Reap the launch opportunity: Product launches allow leveraging global resources for developing an effective and globally scalable engagement programme.

  • The new launch paradigm The new launch paradigm

    To this end, it is imperative that new product launches are executed flawlessly and complement the overall corporate objective for consistent, successful multiple-product launches. ... More positively, the increasing recent and ongoing investment in

More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest appointments

  • Novo Nordisk target Ablynx reshuffles its board Novo Nordisk target Ablynx reshuffles its board

    Hensen is the ideal person to lead the board moving forward and his wealth of experience is particularly relevant as we advance towards the potential approvals and global launches of our ... lead, wholly-owned product, caplacizumab, in addition to

  • Astellas promotes John Demaree Astellas promotes John Demaree

    In his new role, Demaree will lead the promotion of in-market products, the preparation of product launches and will collaborate with Astellas' partner organisations in the region on marketing strategy.

  • The Medicines Company appoints Biogen's Tony Kingsley The Medicines Company appoints Biogen's Tony Kingsley

    Kingsley previously served as Biogen's executive vice president, global commercial operations, where the product launches he oversaw included the multiple sclerosis blockbuster Tecfidera (dimethyl fumerate).

  • Coloplast appoints new learning and development manager Coloplast appoints new learning and development manager

    Michelle has over 17 years of experience in training and development which involved systems training, training for new hires and product launches.

  • Nabriva Therapeutics adds Will Sargent to team Nabriva Therapeutics adds Will Sargent to team

    Sargent has over twenty years of experience in the biopharmaceutical industry, including multiple product and line extension launches. ... Nabriva is currently moving rapidly to advance its lead product, lefamulin, into phase III clinical studies which

More from appointments
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics